Outcome of office hysteroscopy in postmenopausal women with red flag signs: a single centre-based study from Northern Ireland
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20233821Keywords:
Abnormal uterine bleeding, Postmenopausal bleeding, Cancer endometrium, Hysteroscopy, HistopathologyAbstract
Background: Assessment of postmenopausal women with red flag signs like postmenopausal bleeding/ endometrial thickness ≥5 mm is needed for early detection of any pathology. Early-stage endometrial cancer detection through office hysteroscopy is one of crucial modality for effective management. Objective was to assess the outcome of office hysteroscopy in postmenopausal women with red flag sign and correlated with histopathology findings.
Methods: A prospective observational study at a single facility in Northern Ireland involving 122 post-menopausal women aged ≥45 years subjected to AUB/increased endometrial thickness. Advance diagnostic examination by office hysteroscopy followed by histopathology to detect and rule out endometrial cancer and related ailments.
Results: The mean age of the study population was 63.07±10.317 SD years and 91.8% were over-weight. 71.3% women had endometrial thickness <5 mm. Hysteroscopic reported for 8.2% (10 cases) endometrial cancers having diagnostic accuracy of 98.36%. The histological and hysteroscopic diagnoses were having significantly similar outcomes. Office hysteroscopy has 100% specificity and positive predictive value in detecting normal endometrium whereas 98.25% specificity and 100% negative predictive value in case for cancer detection.
Conclusions: In Irish women, office hysteroscopy proved helpful in determining the pathologies that cause postmenopausal bleeding. Correlating hysteroscopic and histological findings with red flag indications should be the focus of future explorations.
References
Clarke MA, Long BJ, Del Mar Morillo A, Arbyn M, Bakkum-Gamez JN, Wentzensen N. Association of Endometrial Cancer Risk With Postmenopausal Bleeding in Women: A Systematic Review and Meta-analysis. JAMA. 2018;178(9):1210-22.
Walker S, Hyde C, Hamilton W. Risk of uterine cancer in symptomatic women in primary care: case-control study using electronic records. Br J Gen Pract. 2013; 63(614):e643-8.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394-424.
Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, et al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. Ann Oncol. 2016;27(1):16-41.
Uterine Cancer Statistics. Available at: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/uterine-cancer#heading-Zero. Accessed on 02 June 2021.
Womb Cancer. Available at: https://www.cancer.ie/ cancer-information-and-support/cancer-types/womb-cancer. Accessed on 2 June 2021.
Factsheets: Uterine cancer 2014. Available at: https://www.qub.ac.uk/researchcentres/nicr/FileStore/OfficialStats2018/Factsheets 2018. Accessed on 2 June 2021.
Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet. 2005;366(9484):491-505.
Cooper NA, Barton PM, Breijer M, Caffrey O, Opmeer BC, Timmermans A, et al. Cost-effectiveness of diagnostic strategies for the management of abnormal uterine bleeding (heavy menstrual bleeding and post-menopausal bleeding): a decision analysis. Health Technol Assess. 2014;18(24):1-201.
Sorosky JI. Endometrial cancer. Obstet Gynecol. 2012; 120(1):383-97.
Colombo N, Preti E, Landoni F, Carinelli S, Colombo A, Marini C, et al. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(6):33-8.
Medverd JR, Dubinsky TJ. Cost analysis model: US versus endometrial biopsy in evaluation of peri- and postmenopausal abnormal vaginal bleeding. Radiology. 2002;222(3):619-27.
Centini G, Troia L, Lazzeri L, Petraglia F, Luisi S. Modern operative hysteroscopy. Minerva Ginecol. 2016;68(2):126-32.
Jacobs I, Gentry-Maharaj A, Burnell M, Manchanda R, Singh N, Sharma A, et al. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort. Lancet Oncol. 2011;12(1):38-48.
Niksic M, Rachet B, Warburton FG, Wardle J, Ramirez AJ, Forbes LJL. Cancer symptom awareness and barriers to symptomatic presentation in England--are we clear on cancer? Br J Cancer. 2015;113(3):533-42.
Best Practice in Outpatient Hysteroscopy, Green-top Guideline No. 59. RCOG. Available at: https://www. rcog.org.uk/globalassets/documents/guidelines/gtg59hysteroscopy.pdf. Accessed on 2 June 2021.
Elkholi DGE, Nagy HM. Unexplained postmenopausal uterine bleeding from atrophic endometrium: Histopathological and hormonal studies. Middle East Fertil Soc J. 2015;20(4):262-70.
Astrup K, Olivarius Nde F. Frequency of spontaneously occurring postmenopausal bleeding in the general population. Acta Obstet Gynecol Scand. 2004;83(2):203-7.
Smith-Bindman R, Weiss E, Feldstein V. How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding. Ultrasound Obstet Gynecol. 2004;24(5):558-65.
Lasmar RB, Dias R, Barrozo PR, Oliveira MA, Coutinho Eda S, da Rosa DB. Prevalence of hysteroscopic findings and histologic diagnoses in patients with abnormal uterine bleeding. Fertil Steril. 2008;89(6):1803-7.
Koutlaki N, Dimitraki M, Zervoudis S, Skafida P, Nikas I, Mandratzi J, et al. Hysteroscopy and endometrial cancer. Diagnosis and influence on prognosis. Gynecol Surg. 2010;7(4):335-41.
Lasmar RB, Barrozo PR, de Oliveira MA, Coutinho ES, Dias R. Validation of hysteroscopic view in cases of endometrial hyperplasia and cancer in patients with abnormal uterine bleeding. J Minimal Invas Gynecol. 2006;13(5):409-12.
Tinelli R, Tinelli FG, Cicinelli E, Malvasi A, Tinelli A. The role of hysteroscopy with eye-directed biopsy in postmenopausal women with uterine bleeding and endometrial atrophy. Menopause. 2008;15(4):737-42.
Alexopoulos ED, Simonis CD, Kidsley S, Fay TN. The value of outpatient hysteroscopy in the management of postmenopausal bleeding: a review of 862 cases. Gynaecol Endos. 2000;9(2):107-12.
De Wit AC, Vleugels MP, De Kruif JH. Diagnostic hysteroscopy: a valuable diagnostic tool in the diagnosis of structural intra-cavital pathology and endometrial hyperplasia or carcinoma?. Six years of experience with non-clinical diagnostic hysteroscopy. Eur J Obstet Gynecol Reprod Biol. 2003;110(1):79-82.
Sreelatha S, Jayanthi SP, Shivananjaiah C, Malapure P, Nataraj HN. Postmenopausal bleeding and its evaluation: Prospective study in a tertiary care center. Int J Clin Obstet Gynaecol. 2017;1(2):48-51.
Clark TJ, Voit D, Gupta JK, Hyde C, Song F, Khan KS. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA. 2002;288(13):1610-21.
Brill AI. What is the role of hysteroscopy in the management of abnormal uterine bleeding? Clin Obstet Gynecol. 1995;38(2):319-45.
